Anodyne
Boston, US · Founded 2019 · 7 known investors
Find your way into Anodyne
Sign up to see every warm intro you have to Anodyne
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Anodyne team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Anodyne Nanotech develops the HeroPatch, a transdermal drug delivery system designed to replace traditional injections for chronic care treatments. The company focuses on simplifying medicine delivery through an alternative to needles and syringes.
Founders & leadership

Board
Investors · 7
How we know: the VCSheet dataset · Not right? Tell us
How we know: Big Pi Ventures's portfolio page · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$16M disclosed across 3 of 5 rounds · 2020–2026
- Undisclosed amountSeries AJun 2026
Velocity Partners VC (lead), Evercurious VC, Relativity Healthcare Partners
Source ↗ - Undisclosed amountSeedMay 2024Source ↗
▶$12.6MraisedJun 2026 · 47 investors · Other Health CareRule 506(b)
- Michael SingerDirector
- Vikram LambaDirector
- Georgios PapastergiouDirector
- Konstantinos TzortzakisExecutive Officer, Director
- Jake LombardoExecutive Officer, Director
- Offering amount
- $17.3M
- Amount sold
- $12.6M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedMay 2021 · 15 investors · Other TechnologyRule 506(b)
- MICHAEL SINGERDirector
- HOJATOLLAH REZAEI NEJADExecutive Officer
- KONSTANTINOS TZORTZAKISExecutive Officer, Director
- LOMBARDO JAKEExecutive Officer
- LAMPROS KOURTISDirector
- ACHILLEAS GRAVANISDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.5MraisedAug 2020 · 20 investors · Other TechnologyRule 506(b)
- KONSTANTINOS TZORTZAKISExecutive Officer, Director
- ACHILLEAS GRAVANISDirector
- LOMBARDO JAKEExecutive Officer
- LAMPROS KOURTISDirector
- MICHAEL SINGERDirector
- HOJATOLLAH REZAEI NEJADExecutive Officer
- Offering amount
- $2.3M
- Amount sold
- $1.5M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Patch, not needle: Anodyne raises $12.6m for GLP-1 obesity patchlongevity.technology · Jun 2026Frequently asked questions
- What does Anodyne do?
- Anodyne Nanotech develops the HeroPatch, a transdermal drug delivery system designed to replace traditional injections for chronic care treatments. The company focuses on simplifying medicine delivery through an alternative to needles and syringes.
- Who are Anodyne's investors?
- Anodyne's investors include Bantam Group, Big Pi Ventures, Deep Capital Group, EvercuriousVC.
- How much funding has Anodyne raised?
- Anodyne has disclosed $16M raised across 3 of its 5 known rounds.
- Where is Anodyne headquartered?
- Anodyne is headquartered in Boston, US.
